Loading...
•
Jun 30, 2022
Teladoc Q2 2022 Earnings Report
Teladoc Health's second quarter results were reported, revealing revenue growth but a significant net loss due to a goodwill impairment charge.
Key Takeaways
Teladoc Health's Q2 2022 earnings report showed an 18% increase in revenue year-over-year, reaching $592.4 million. However, the company reported a significant net loss of $3,101.5 million, or $19.22 per share, primarily due to a non-cash goodwill impairment charge of $3.0 billion.
Revenue increased by 18% year-over-year to $592.4 million.
Net loss was $3,101.5 million, or $19.22 per share, impacted by a $3.0 billion non-cash goodwill impairment charge.
Access fees revenue grew 20% to $518.7 million.
U.S. revenue increased 18% to $521.4 million, while international revenue grew 13% to $71.0 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health is maintaining its previously issued revenue and adjusted EBITDA outlook for the fiscal year ending December 31, 2022, but expects results to be toward the lower end of those ranges.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...